BITGF Stock - Biotage AB (publ)
Unlock GoAI Insights for BITGF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.06B | $1.86B | $1.57B | $1.23B | $1.09B |
| Gross Profit | $1.29B | $1.15B | $948.00M | $755.00M | $667.00M |
| Gross Margin | 62.7% | 61.7% | 60.5% | 61.3% | 61.1% |
| Operating Income | $383.00M | $314.00M | $327.00M | $271.00M | $206.00M |
| Net Income | $284.00M | $246.00M | $268.00M | $205.00M | $175.00M |
| Net Margin | 13.8% | 13.2% | 17.1% | 16.6% | 16.0% |
| EPS | $3.55 | $0.33 | $0.39 | $0.35 | $0.33 |
Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Visit WebsiteEarnings History & Surprises
BITGFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 21, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | — | — | — | — |
Q4 2025 | Oct 23, 2025 | — | — | — | — |
Q3 2025 | Aug 6, 2025 | — | — | — | — |
Q2 2025 | Apr 24, 2025 | $0.02 | $0.00 | -77.2% | ✗ MISS |
Q1 2025 | Feb 19, 2025 | $0.14 | $0.18 | +23.2% | ✓ BEAT |
Q4 2024 | Oct 23, 2024 | $0.07 | $0.05 | -16.7% | ✗ MISS |
Q3 2024 | Jul 16, 2024 | $0.06 | $0.06 | -7.1% | ✗ MISS |
Q2 2024 | Apr 25, 2024 | $0.05 | $0.04 | -23.2% | ✗ MISS |
Q1 2024 | Feb 15, 2024 | $0.08 | $0.17 | +104.5% | ✓ BEAT |
Q3 2023 | Sep 29, 2023 | $0.06 | $0.04 | -22.6% | ✗ MISS |
Q2 2023 | Jun 29, 2023 | $0.07 | $0.05 | -38.6% | ✗ MISS |
Q1 2023 | Mar 30, 2023 | $0.07 | $0.06 | -5.0% | ✗ MISS |
Q1 2023 | Feb 15, 2023 | $1.40 | $1.11 | -20.7% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $1.06 | $0.98 | -7.5% | ✗ MISS |
Q3 2022 | Jul 19, 2022 | $0.84 | $0.87 | +3.6% | ✓ BEAT |
Q2 2022 | Apr 28, 2022 | $0.86 | $1.08 | +25.6% | ✓ BEAT |
Q1 2022 | Feb 11, 2022 | $0.86 | $0.69 | -19.8% | ✗ MISS |
Q4 2021 | Oct 28, 2021 | — | $0.09 | — | — |
Q3 2021 | Jul 16, 2021 | — | $0.08 | — | — |
Latest News
Frequently Asked Questions about BITGF
What is BITGF's current stock price?
What is the analyst price target for BITGF?
What sector is Biotage AB (publ) in?
What is BITGF's market cap?
Does BITGF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BITGF for comparison